Trials / Active Not Recruiting
Active Not RecruitingNCT06913400
Progression of Stereopsis Recovery in Strabismic Patients: A One-Month and Three-Month Post-Surgery Evaluation
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- Superior University · Academic / Other
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
This prospective longitudinal observational study aims to assess stereopsis recovery in strabismic patients at one month and three months post-corrective surgery. The study will be conducted at Mayo Hospital, Lahore, and Sajjad Eye Center, Burewala, with a sample size of 34 using a purposive sampling technique. Eligible participants include patients aged ≥5 years undergoing strabismus surgery for esotropia, exotropia, or vertical deviations, with best-corrected visual acuity (BCVA) of 6/12 in both eyes. Patients with previous strabismus surgery, amblyopia, neurological conditions, or sensory strabismus will be excluded.
Detailed description
Baseline assessments include visual acuity (Snellen Chart), ocular alignment (cover-uncover and prism cover tests), and stereopsis (Titmus Fly Test). The same tests will be repeated one month and three months post-surgery to evaluate changes. The study aims to determine whether strabismus surgery enhances binocular function and stereopsis, helping guide future treatment strategies. Data will be analyzed using paired t-tests to assess differences over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Stereopsis Recovery | This prospective longitudinal observational study aims to assess stereopsis recovery in strabismic patients at one month and three months post-corrective surgery |
Timeline
- Start date
- 2025-03-20
- Primary completion
- 2025-06-20
- Completion
- 2026-02-20
- First posted
- 2025-04-06
- Last updated
- 2025-04-06
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06913400. Inclusion in this directory is not an endorsement.